Shenzhen Hepalink Pharmac... (SHEZF)

PNK: SHEZF · Real-Time Price · USD

0.47

0.00 (0.09%)

At close: Apr 30, 2025, 8:00 PM

Shenzhen Hepalink Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.69B	1.85B	2.14B	2.94B	2.71B	1.28B	2.12B	3.5B	4.55B
Short-Term Investments	868.42M	414.18M	1.31B	981.16M	828.21M	112.64M	79.22M	293.19M	13.4M
Long-Term Investments	955.08M	2.1B	1.15B	1.64B	3.17B	3.17B	1.99B	2.3B	1.47B
Other Long-Term Assets	1.07B	729.4M	1.73B	1.3B	1.24B	348.51M	440.18M	164.73M	271.98M
Receivables	1.28B	1.27B	1.63B	1.54B	1.69B	1.32B	1.09B	712.5M	560.53M
Inventory	5.39B	6.65B	6.84B	4.71B	3.17B	2.37B	1.53B	857.27M	584.83M
Other Current Assets	322.41M	177.92M	469.36M	151.2M	651.49M	914.42M	861.24M	694.42M	721.87M
Total Current Assets	9.62B	10.6B	12.39B	10.77B	9.13B	6B	5.6B	6.13B	6.7B
Property-Plant & Equipment	2.65B	2.63B	2.48B	2.54B	2.57B	2.58B	2.35B	1.61B	1.22B
Goodwill & Intangibles	2.76B	2.82B	2.92B	2.74B	2.83B	3.04B	3.06B	2.84B	3.05B
Total Long-Term Assets	7.72B	8.6B	8.42B	8.34B	9.9B	9.25B	8.06B	7.06B	6.21B
Total Assets	17.34B	19.2B	20.81B	19.11B	19.03B	15.24B	13.66B	13.19B	12.91B
Account Payables	299.69M	302.22M	427.43M	385.79M	239.22M	228.66M	205.27M	167.65M	48.59M
Deferred Revenue	n/a	n/a	433.88M	1.1B	862.47M	584.67M	1.57B	169.62M	160.86M
Short-Term Debt	1.84B	1.88B	4.06B	1.89B	1.86B	2.93B	2.46B	1.69B	462.75M
Other Current Liabilities	831.32M	2.15B	1.00	1.42B	651.38M	1.81B	263.29M	1.71B	1.38B
Total Current Liabilities	3.7B	4.99B	5.58B	4.79B	3.61B	4.97B	4.5B	3.25B	2.07B
Long-Term Debt	1.08B	1.81B	2.3B	2.25B	3.14B	2.35B	2.45B	1.82B	2.1B
Other Long-Term Liabilities	33.57M	328.42M	61.87M	147.09M	88.51M	118.79M	76.98M	84.44M	89.17M
Total Long-Term Liabilities	1.44B	2.23B	2.83B	2.79B	3.72B	2.8B	2.91B	2.25B	2.76B
Total Liabilities	5.14B	7.22B	8.41B	7.58B	7.34B	7.77B	7.41B	5.5B	4.83B
Total Debt	2.98B	3.78B	6.46B	5.65B	5.65B	6.3B	4.92B	4.71B	3.89B
Common Stock	1.47B	1.47B	1.47B	1.47B	1.47B	1.25B	1.25B	1.25B	1.25B
Retained Earnings	4.03B	3.39B	4.31B	3.65B	3.67B	2.88B	1.94B	1.4B	1.59B
Comprehensive Income	n/a	158.46M	843.39M	563.88M	693.97M	798.25M	801.29M	726.14M	885.44M
Shareholders Equity	12.15B	11.91B	12.31B	11.41B	11.57B	7.35B	6.07B	7.58B	7.97B
Total Investments	1.82B	2.51B	2.46B	2.62B	4B	3.28B	2.07B	2.08B	1.49B